MAR 28, 2020 7:21 AM PDT

FDA Approves 5-Minute Coronavirus Test

WRITTEN BY: Annie Lennon

In recent weeks, the US has struggled to supply enough tests to detect the coronavirus. Now, however, this may change thanks to the FDA’s approval of a rapid-testing device by Abbott Laboratories capable of telling if someone is infected with the virus in just five minutes. 

John Frels, vice president of research and development at Abbott Diagnostics, said, “This is really going to provide a tremendous opportunity for front-line caregivers, those having to diagnose a lot of infections, to close the gap with our testing...A clinic will be able to turn that result around quickly, while the patient is waiting.”

To take the test, medical practitioners must take a swab from a patient’s nose or the back of their throat. Then mixing the swab in a chemical solution to break the virus down and release its RNA for identification, it is then inserted into an ID Now system, a box weighing less than 7 pounds. This box then identifies and reads select sequences relevant to the coronavirus genome. Taking just five minutes to deliver positive results when the patient has a high viral load, a more thorough analysis to rule out the virus altogether takes up to 13 minutes. 

Abbott Diagnostics has said that they will be able to make 50,000 of these tests per day from April 1st, and that they can be used in practically any healthcare setting. Thus, the US government initially plans on delivering them to where they are most needed- particularly in hospital emergency rooms, urgent-care clinics and doctors’ offices. 

This news comes after the FDA’s approval of Abbott’s m2000 RealTime system, another diagnostic technique that, although takes longer to produce results, can be produced at a much faster rate: up to 1 million tests per week. The two systems taken together mean that Abbott will soon be able to create at least 5 million tests per month. 

Meanwhile, other companies have also been working hard to deliver diagnostic tools for the coronavirus. Henry Schein Inc, for example, announced the availability of its point-of care antibody test. Looking for evidence that a person’s immune system has already fought off the virus, the blood test delivers results within 15 minutes, although it can’t be used to detect current infections. 


Sources: Bloomberg, Chicago Business and CNN 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 26, 2020
Cancer
NAP-6: A Potential Candidate for the Treatment of Breast Cancer
AUG 26, 2020
NAP-6: A Potential Candidate for the Treatment of Breast Cancer
The body is an amazing and complex system of pathways, all working together in harmony. However, cancer can quickly disr ...
AUG 26, 2020
Drug Discovery & Development
Can Sugar Cause A Leaky Gut?
AUG 26, 2020
Can Sugar Cause A Leaky Gut?
Can Sugar Cause A Leaky Gut? Apparently, research at the University of California San Diego School of Medicine seems to ...
SEP 11, 2020
Drug Discovery & Development
Novel Therapeutic for ALS
SEP 11, 2020
Novel Therapeutic for ALS
The TDP-43 protein is a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). A ...
SEP 19, 2020
Drug Discovery & Development
Novel Drug Delivery System for Neurological Diseases
SEP 19, 2020
Novel Drug Delivery System for Neurological Diseases
Scientists at Rutgers have developed a smart drug delivery system that targets inflammation in damaged nerves and helps ...
OCT 12, 2020
Drug Discovery & Development
In vitro glycoengineering - Suitability for BioPharma manufacturing
OCT 12, 2020
In vitro glycoengineering - Suitability for BioPharma manufacturing
Introduction The importance of Fc glycosylation of monoclonal antibodies (mAbs) with regard to biological activity is wi ...
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
Loading Comments...